FXR1 Promotes Esophageal Squamous Cell Carcinoma via JAK2/STAT3/B7-H3 Pathway
Anticancer Research · 2026
DOI: 10.21873/anticanres.18391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Xiaoli Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Affiliated Hospital of Jiangnan University, Jiangsu, P.R. China. Hauptthemen laut MEDLINE: Janus Kinase 2, STAT3 Transcription Factor, RNA-Binding Proteins, Esophageal Squamous Cell Carcinoma.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The Affiliated Hospital of Jiangnan University, Jiangsu, P.R. China.
- Department of Oncology, The Affiliated Hospital of Jiangnan University, Jiangsu, P.R. China.
- Department of Pharmacy, The Affiliated Hospital of Jiangnan University, Jiangsu, P.R. China.
- Institute of Oncology, The Affiliated Hospital of Jiangnan University, Jiangsu, P.R. China.
- Department of Oncology, The Affiliated Hospital of Jiangnan University, Jiangsu, P.R. China; 9862016040@jiangnan.edu.cn.
Zitieren
APA
Wang, X., Miao, Q., Liu, X., Liu, F., Zhang, Y., Shen, C., Wang, F., Shen, D. I., & Ge, X. (2026). FXR1 Promotes Esophageal Squamous Cell Carcinoma via JAK2/STAT3/B7-H3 Pathway. Anticancer Research. https://doi.org/10.21873/anticanres.18391
Vancouver
Wang X, Miao Q, Liu X, Liu F, Zhang Y, Shen C, et al. FXR1 Promotes Esophageal Squamous Cell Carcinoma via JAK2/STAT3/B7-H3 Pathway. Anticancer Research. 2026. doi:10.21873/anticanres.18391
BibTeX
@article{Wang2026,
author = {Wang, Xiaoli and Miao, Qianwen and Liu, Xiaoyuan and Liu, Fen and Zhang, Ying and Shen, Cailu and Wang, Fang and Shen, D I and Ge, Xiaosong},
title = {FXR1 Promotes Esophageal Squamous Cell Carcinoma via JAK2/STAT3/B7-H3 Pathway},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18391}
}
EUVIMED